Reime Monika Alvestad, Løseth Hilde-Margit, Lindeman Sari Kaarina, Titlestad Kristine Berg, Dyregrov Kari, Selseng Lillian Bruland
Western Norway University of Applied Sciences, Bergen, Norway.
Nordisk Alkohol Nark. 2022 Aug;39(4):453-465. doi: 10.1177/14550725221085345. Epub 2022 May 2.
Drug-related death (DRD) is a major public health concern in the Nordic countries, in the rest of Europe and in the US. After a DRD, approximately 10-15 next of kin will be left behind. People bereaved after sudden and unexpected deaths have a documented higher risk of reduced quality of life, daily functioning, and early death. It is important to know the resources professional helpers have available to them, the barriers and possibilities they face in their work, and how they can respond to the needs of the bereaved. This knowledge can help prevent severe health and social consequences of bereavement following a DRD. In this systematic review, the aim was to explore knowledge regarding professional helpers' experiences of providing assistance to people bereaved after a DRD. Inclusion criteria were empirical studies of professional helpers' first-person perspectives on meeting the bereaved after a DRD. Quantitative, qualitative, and mixed-method studies were included. The results show that there are no studies addressing professional helpers' experiences of providing assistance to the bereaved after a DRD. There is a vital need to develop more knowledge of professional helpers' perspectives. This knowledge is important not only to improve education and the quality of health and social services, but also to help raise awareness of the bereaved after a DRD.
药物相关死亡（DRD）是北欧国家、欧洲其他地区以及美国的一个主要公共卫生问题。一次药物相关死亡之后，大约会有10至15名近亲遗留下来。有记录表明，经历突然和意外死亡的遗属生活质量下降、日常功能受影响以及过早死亡的风险更高。了解专业救助人员可利用的资源、他们在工作中面临的障碍和可能性，以及他们如何回应遗属的需求非常重要。这些知识有助于预防药物相关死亡后丧亲之痛带来的严重健康和社会后果。在这项系统评价中，目的是探索关于专业救助人员为药物相关死亡后丧亲者提供援助的经验的知识。纳入标准是对专业救助人员在药物相关死亡后与丧亲者接触的第一人称视角的实证研究。纳入了定量研究、定性研究和混合方法研究。结果表明，尚无研究探讨专业救助人员为药物相关死亡后丧亲者提供援助的经验。迫切需要更多地了解专业救助人员的观点。这些知识不仅对于改善教育以及卫生和社会服务质量很重要，而且有助于提高对药物相关死亡后丧亲者的认识。
